Douglas R Dougan

Author PubWeight™ 22.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase. J Biol Chem 2004 3.79
2 Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure 2004 3.31
3 Structural basis for bisphosphonate-mediated inhibition of isoprenoid biosynthesis. J Biol Chem 2003 2.06
4 Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer. Bioorg Med Chem Lett 2011 1.20
5 High resolution structure of an alternate form of the ferric ion binding protein from Haemophilus influenzae. J Biol Chem 2003 0.97
6 Structural basis for iron binding and release by a novel class of periplasmic iron-binding proteins found in gram-negative pathogens. J Bacteriol 2004 0.95
7 Crystal structure of Pasteurella haemolytica ferric ion-binding protein A reveals a novel class of bacterial iron-binding proteins. J Biol Chem 2003 0.90
8 Crystal structures of active fully assembled substrate- and product-bound complexes of UDP-N-acetylmuramic acid:L-alanine ligase (MurC) from Haemophilus influenzae. J Bacteriol 2003 0.89
9 Novel anion-independent iron coordination by members of a third class of bacterial periplasmic ferric ion-binding proteins. J Biol Chem 2004 0.87
10 Presence of ferric hydroxide clusters in mutants of Haemophilus influenzae ferric ion-binding protein A. Biochemistry 2003 0.84
11 A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) γ agonists: design and synthesis of benzylpyrazole acylsulfonamides. Bioorg Med Chem 2011 0.83
12 Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta. Bioorg Med Chem 2009 0.81
13 2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta with good brain permeability. J Med Chem 2009 0.79
14 Structure-based design and synthesis of pyrrole derivatives as MEK inhibitors. Bioorg Med Chem Lett 2010 0.79
15 Discovery of novel benzo[b][1,4]oxazin-3(4H)-ones as poly(ADP-ribose)polymerase inhibitors. Bioorg Med Chem Lett 2013 0.78
16 Design and synthesis of potent inhibitor of apoptosis (IAP) proteins antagonists bearing an octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline mimetic. J Med Chem 2013 0.77
17 Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells. Bioorg Med Chem 2013 0.76
18 Design, synthesis, and structure-activity relationships of spirolactones bearing 2-ureidobenzothiophene as acetyl-CoA carboxylases inhibitors. Bioorg Med Chem Lett 2011 0.76
19 Design, stereoselective synthesis, and biological evaluation of novel tri-cyclic compounds as inhibitor of apoptosis proteins (IAP) antagonists. Bioorg Med Chem 2013 0.76
20 Structure-activity relationships and key structural feature of pyridyloxybenzene-acylsulfonamides as new, potent, and selective peroxisome proliferator-activated receptor (PPAR) γ Agonists. Bioorg Med Chem 2012 0.75